These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10380572)

  • 61. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.
    Spudick JM; Garcia LS; Graham DM; Haake DA
    J Clin Microbiol; 2005 Feb; 43(2):978-81. PubMed ID: 15695723
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
    Price RN; Douglas NM; Anstey NM
    Curr Opin Infect Dis; 2009 Oct; 22(5):430-5. PubMed ID: 19571748
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India.
    Nandy A; Addy M; Maji AK; Bandyopadhyay AK
    Ann Trop Med Parasitol; 2003 Apr; 97(3):215-20. PubMed ID: 12803853
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of Plasmodium vivax malaria--time for a change?
    Doherty JF; Day JH; Warhurst DC; Chiodini PL
    Trans R Soc Trop Med Hyg; 1997; 91(1):76. PubMed ID: 9093635
    [No Abstract]   [Full Text] [Related]  

  • 66. Malaria during pregnancy in a reference centre from the Brazilian Amazon: unexpected increase in the frequency of Plasmodium falciparum infections.
    Martínez-Espinosa FE; Daniel-Ribeiro CT; Alecrim WD
    Mem Inst Oswaldo Cruz; 2004 Feb; 99(1):19-21. PubMed ID: 15057341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasmodium vivax polymorphism in a clinical drug trial.
    Adak T; Valecha N; Sharma VP
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):891-4. PubMed ID: 11527798
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
    Pukrittayakamee S; Vanijanonta S; Chantra A; Clemens R; White NJ
    J Infect Dis; 1994 Apr; 169(4):932-5. PubMed ID: 8133114
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Three unusual presentations of plasmodium vivax malaria.
    Sonkar SK; Uniyal R; Sonkar GK
    Trop Doct; 2011 Oct; 41(4):240-1. PubMed ID: 21926116
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala.
    Gascon J; Gomez Arce JE; Menendez C; Valls ME; Corachán M
    Trop Geogr Med; 1994; 46(1):32-3. PubMed ID: 8165734
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.
    Faucher JF; Bellanger AP; Shaniya N; Hustache-Mathieu L; Hoen B; Chirouze C
    Med Mal Infect; 2014 Aug; 44(8):387-9. PubMed ID: 25015307
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasmodium vivax malaria presenting with skin rash--a case report.
    Zaki SA; Shanbag P
    J Vector Borne Dis; 2011 Dec; 48(4):245-6. PubMed ID: 22297289
    [No Abstract]   [Full Text] [Related]  

  • 73. Chronic Plasmodium vivax infection in a patient with splenomegaly and severe thrombocytopenia.
    Lacerda MV; Hipólito JR; Passos LN
    Rev Soc Bras Med Trop; 2008; 41(5):522-3. PubMed ID: 19009202
    [No Abstract]   [Full Text] [Related]  

  • 74. A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax.
    Gogtay N; Garg M; Kadam V; Kamtekar K; Kshirsagar NA
    Trans R Soc Trop Med Hyg; 1998; 92(3):341. PubMed ID: 9861412
    [No Abstract]   [Full Text] [Related]  

  • 75. A local outbreak of autochthonous Plasmodium vivax malaria in Laconia, Greece--a re-emerging infection in the southern borders of Europe?
    Andriopoulos P; Economopoulou A; Spanakos G; Assimakopoulos G
    Int J Infect Dis; 2013 Feb; 17(2):e125-8. PubMed ID: 23098813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primaquine and
    Greenwood B; Drakeley C
    N Engl J Med; 2022 Mar; 386(13):1282-1283. PubMed ID: 35353968
    [No Abstract]   [Full Text] [Related]  

  • 77. The neglected Plasmodium vivax: are researchers from endemic areas really concerned about new treatment options?
    de Lacerda MV; Zackiewicz C; Alecrim WD; Alecrim Md
    Rev Soc Bras Med Trop; 2007; 40(4):489-90. PubMed ID: 17876480
    [No Abstract]   [Full Text] [Related]  

  • 78. Plasmodium vivax in India.
    Joshi H; Prajapati SK; Verma A; Kang'a S; Carlton JM
    Trends Parasitol; 2008 May; 24(5):228-35. PubMed ID: 18403267
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Vivax malaria with long incubation period, detected in the Federal District: three case reports].
    Tauil PL; Luz Fd; Oliveira AP; Deckers FA; Santos JB
    Rev Soc Bras Med Trop; 2010; 43(2):213-4. PubMed ID: 20464158
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Imported Plasmodium vivax malaria in France: geographical origin and report of an atypical case acquired in Central or Western Africa.
    Gautret P; Legros F; Koulmann P; Rodier MH; Jacquemin JL
    Acta Trop; 2001 Feb; 78(2):177-81. PubMed ID: 11230828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.